[{"name":"Novel Targeted Therapies for MBC - Tyrosine kinase inhibitors (ID 836)","mode":"","is_cme":false,"info":{"presentation":"Novel Targeted Therapies for MBC - Tyrosine kinase inhibitors <small>(ID 836)<\/small>","session":"CME Webinar Supported by Daiichi Sankyo - Industry Satellite Symposium: Novel Therapies for Relapsed or Refractory HER2- Positive Metastatic Breast Cancer <small>(ID 83)<\/small>","presenter":"Cristina Saura Manich<small> (Barcelona, Spain)<\/small>","photo":null},"playlist":[{"name":"Novel Targeted Therapies for MBC - Tyrosine kinase inhibitors","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/breast2020\/83\/v\/836_1c.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/breast2020\/83\/v\/836_1c.mp4","cover":"","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/breast2020\/83\/v\/836_1c.vtt","thumbnails":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/breast2020\/83\/v\/836_1c-thumbnails.vtt"}]}]{"provider":"CTI","provider_live":0,"type":1,"code":"7L240fq02Vk"}